Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about Merck's Glucophage(R) extended release (XR) can be used for more type 2 diabetes patients
Merck a leading science and technology company, announced that the British Medicines and Healthcare products Regulatory Agency (MHRA), has approved on November 2 an updated labeling for Glucophage® XR (extended release metformin) for the treatment of patients with type 2 diabetes. The label change removes moderate renal impairment stage 3a and stable chronic heart failure from the list of the contraindications of Glucophage® XR.

[adsense:336x280:8701650588]
- Read more about Merck KGaA, Darmstadt, Germany, and Pfizer Announce Initiation of Phase III First-Line Trial of Avelumab in Patients with Recurrent or Stage IV Non-Small Cell Lung Cancer(NSCLC)
Merck KGaA, Darmstadt, Germany, and Pfizer announced the initiation of an international Phase III study of the investigational cancer immunotherapy avelumab* in a treatment naïve advanced NSCLC setting. The study, JAVELIN Lung 100, is designed to assess the safety and efficacy of avelumab compared with platinum-based doublet chemotherapy, in patients with late-stage NSCLC who have not previously received any treatment for their systemic lung cancer. Avelumab (previously known as MSB0010718C) is an investigational fully human anti-PD-L1 IgG1 monoclonal antibody that potentially uses the body’s own immune system to fight cancer.
- Read more about Johnson & Johnson announces agreement to acquire Novira Therapeutics, inc.
Johnson & Johnson announced a definitive agreement to acquire Novira Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company developing novel therapies for curative treatment of chronic hepatitis B virus (HBV) infection. The acquisition includes Novira’s portfolio of novel antivirals, including its lead candidate, NVR 3-778. Financial terms of the transaction have not been disclosed.
- Read more about GSK’s Nucala® (mepolizumab) receives approval from US FDA
GlaxoSmithKline plc received approval from the US Food and Drug Administration (FDA) for its Biologics License Application (BLA) for Nucala® (mepolizumab) as an add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype. Nucala is not approved for the treatment of other eosinophilic conditions or relief of acute bronchospasm or status asthmaticus.
- Read more about IPC set to become the first WHO Collaborating Centre for Safety of Medicines and Vaccines in South-East Asia
The Indian Pharmacopoeia Commission (IPC) is set to become the first WHO Collaborating Centre for Safety of Medicines and Vaccines in the South-East Asia Region. This was stated by Shri J P Nadda, Union Minister of Health and Family Welfare while addressing the 38th Annual Meeting of Representatives of the National Pharmacovigilance Centres participating in the World Health Organization Programme for International Drug Monitoring, organized by the Indian Pharmacopoeia Commission (IPC) and World Health Organization (WHO).
- Read more about Dr Reddy's Lab receives FDA warning over three facilities
Leading drugmaker Dr Reddy's Laboratories today acknowledged having received a warning letter from the US FDA relating to its three manufacturing plants in Andhra Pradesh and Telangana.
- Read more about NIPERs and Pharma Industries bridged to fulfill academic and industry gap
National Institutes for Pharmaceutical Education and Research (NIPERs) and Pharma Industries signed 17 MoU to bridge gap betwwen academic education and industrial needs. One of the critical factors in building innovation ecosystem and for Drug Discovery is Academia-Industry linkage. Department of Pharmaceuticals (DoP) for the last one year has actively engaged both the NIPERs and the Pharma Industry to build partnership in areas of education, research and development.
- Read more about Omega 3 supplements ineffective in depression
Widely thought to be essential for good health, Omega 3 fatty acid supplements may not be of much help in treating major depressive disorders, suggests new research.
- Read more about Piramal Enterprises Acquires the Baby Care Brand - Little's for the Consumer Products Business
(Business Wire India); Piramal Enterprises’ Consumer Products Division announces the acquisition of the baby-care brand “Little’s”, which includes the entire product range across six categories.
- Read more about Premature ejaculation is not a true illness: Study
Premature ejaculation including female sexual dysfunction should not be classified as an illness, argue researchers, adding that the illness factor may have been constructed by sexual medicine experts under the influence of drug companies.